<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Introduction - A 3M Framework for Multi-omics Biobank Development</title>
    <!-- Google Fonts -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;500;600;700&family=Roboto:wght@300;400;500;700&display=swap" rel="stylesheet">
    <!-- Font Awesome for icons -->
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <!-- Custom styles -->
    <link rel="stylesheet" href="style.css">
</head>
<body>
    <header>
        <div class="header-content">
            <h1>A 3M Framework for Multi-omics Biobank Development</h1>
            <p><em>Zhao Sun<sup>1#</sup>, Xuejiao Xia<sup>1#</sup>, Rui Deng<sup>1</sup>, Jiahui Li<sup>1</sup>, Guanghui Li<sup>1</sup>, Mingliang Yuan<sup>1</sup>, Sanfei Peng<sup>1</sup>, Xiang-yang Yin<sup>1</sup>, Zhiwei Zhao<sup>1</sup>, Xinhua Dong<sup>1</sup>, Qi Liu<sup>1</sup>, Zhen Yang<sup>1*</sup>, Yang Fu<sup>1*</sup></em></p>
        </div>
        <nav>
            <ul>
                <li><a href="index.html"><i class="fas fa-home"></i> Home</a></li>
                <li><a href="introduction.html" class="active"><i class="fas fa-book-open"></i> Introduction</a></li>
                <li><a href="omics.html"><i class="fas fa-dna"></i> Omics Requirements</a></li>
                <li><a href="sample_management.html"><i class="fas fa-vials"></i> Sample Management</a></li>
                <li><a href="ethics.html"><i class="fas fa-file-contract"></i> Ethics & Security</a></li>
                <li><a href="workflow.html"><i class="fas fa-project-diagram"></i> Biobank Workflow</a></li>
                <li><a href="authors.html"><i class="fas fa-users"></i> Contact Us</a></li>
            </ul>
        </nav>
    </header>

    <main>
        <div class="page-header">
            <h2><i class="fas fa-book-open"></i> Introduction</h2>
            <div class="breadcrumb">
                <a href="index.html">Home</a> <i class="fas fa-chevron-right"></i> Introduction
            </div>
        </div>

        <section id="abstract" class="card content-section">
            <h3><i class="fas fa-file-alt"></i> Abstract</h3>
            <div class="abstract-content">
                <p><strong>Background:</strong> Omics-based technologies have significantly advanced precision medicine, relying on high-quality biobanks to meet technical demands. However, universal guidance for end-to-end management of biospecimen collection during patient hospitalization is still lacking, leading to significant bias in subsequent integrated omics analyses.</p>
                <p><strong>Aim of Review:</strong> This review aims to systematically summarize the requirements of multi-omics technologies for biological samples and propose a standardized multimodal biospecimen management framework.</p>
                <p><strong>Key Scientific Concepts:</strong> This study proposes a framework encompassing: (1) multimodal biospecimen volume requirements for each omics type; (2) standard protocols for multimodal biospecimen collection, transport, and storage, including tissue, serum, saliva, urine, and faeces; (3) ethical compliance; and (4) quality control (QC) and data management, including metadata collection and other processes. This framework facilitates standardized multimodal biospecimen management, thereby accelerating precision oncology development based on omics technologies.</p>
            </div>
        </section>

        <section id="introduction" class="card content-section">
            <h3><i class="fas fa-history"></i> Introduction Background</h3>
            <div class="intro-content">
                <p>Biobanks, encompassing programmatic biomaterials, associated information, and legal considerations involving data security and protection[1, 2] , are cornerstones of biomedical research. Their evolution mirrors a shift from disease-specificity towards multidimensional data integration. The 1990s witnessed the emergence of biobanks, primarily disease-oriented and limited in scope[3-5]. As biological research progressed, complex disease-gene relationships became evident. The Human Genome Project (HGP), aimed at comprehensively exploring human genetic information, concluded successfully in 2003. Subsequently, biobanks primarily supporting genomic research emerged [6-8], yet they faced limitations in data dimensionality[9]. Breakthroughs in high-throughput technologies spurred the systematic integration of omics (e.g., genomics, proteomics, metabolomics), enabling comprehensive or near-comprehensive analysis of cellular components like RNA and DNA[10]. This propelled biobanks towards multi-omics data centres. Notable examples include the UK Biobank, releasing genomic and phenotypic data for 500,000 individuals[11], and The Cancer Genome Atlas (TCGA), a multi-omics cancer database[12], providing crucial resources for precision medicine.</p>
            </div>
            
            <h3><i class="fas fa-lightbulb"></i> Impact of Multi-Omics Technologies</h3>
            <div class="intro-content">
                <p>The advent of multi-omics technologies has revolutionized biomedical research by enabling systematic exploration of biological systems. These technologies generate large-scale datasets capturing genetic, molecular, and functional dynamics, offering unprecedented insights into disease mechanisms and personalized therapies. However, their success hinges on the availability of high-quality biospecimens, highlighting the critical role of biobanks. Currently, biobanks worldwide operate largely as localized entities, often established to serve specific research objectives, resulting in a fragmented landscape. In this context, constructing multi-omics-oriented biobanks requires integrating multidimensional biomarkers and establishing a standardized framework across platforms to support the entire innovation spectrum, from basic research to clinical translation.</p>
            </div>
        </section>

        <section class="card content-section">
            <h3><i class="fas fa-project-diagram"></i> Project Significance and Objectives</h3>
            <div class="intro-content">
                <p>This project aims to fill the current gaps in biobank management, particularly regarding the standardization of sample collection and management for multi-omics research. By establishing a comprehensive framework, we expect to address the following key issues:</p>
                <ul class="project-goals">
                    <li><i class="fas fa-check-circle"></i> Establish specific requirement standards for different types of biological samples for multi-omics research</li>
                    <li><i class="fas fa-check-circle"></i> Standardize the entire process of biological sample collection, processing, and storage</li>
                    <li><i class="fas fa-check-circle"></i> Ensure ethical compliance and data security management</li>
                    <li><i class="fas fa-check-circle"></i> Provide quality control standards and metadata collection specifications</li>
                </ul>
                <p>By achieving these objectives, this project will promote the standardization of multi-omics research and data comparability, accelerating the progress of precision medicine.</p>
            </div>
        </section>

        <section class="reference-section card">
            <h3><i class="fas fa-book"></i> References</h3>
            <ol class="references">
                <li>Kinkorová J: Biobanks in the era of personalized medicine: objectives, challenges, and innovation: Overview. The EPMA journal 2015, 7(1):4.</li>
                <li>Greely HT: The uneasy ethical and legal underpinnings of large-scale genomic biobanks. Annual review of genomics and human genetics 2007, 8:343-364.</li>
                <li>Nørgaard‐Pedersen B, Simonsen HJAp: Biological specimen banks in neonatal screening. 1999, 88:106-109.</li>
                <li>Shepherd J, Blauw GJ, Murphy MB, Cobbe SM, Bollen EL, Buckley BM, Ford I, Jukema JW, Hyland M, Gaw AJTAjoc: The design of a prospective study of pravastatin in the elderly at risk (PROSPER). 1999, 84(10):1192-1197.</li>
                <li>Loft S, Poulsen HEJJomm: Cancer risk and oxidative DNA damage in man. 1996, 74:297-312.</li>
                <li>Kang B, Park J, Cho S, Lee M, Kim N, Min H, Lee S, Park O, Han B: Current status, challenges, policies, and bioethics of biobanks. Genomics & informatics 2013, 11(4):211-217.</li>
                <li>Collins FS, Patrinos A, Jordan E, Chakravarti A, Gesteland R, Walters L: New goals for the U.S. Human Genome Project: 1998-2003. Science (New York, NY) 1998, 282(5389):682-689.</li>
                <li>Cambon-Thomsen A, Ducournau P, Gourraud PA, Pontille D: Biobanks for genomics and genomics for biobanks. Comparative and functional genomics 2003, 4(6):628-634.</li>
                <li>Pontén F, Schwenk JM, Asplund A, Edqvist PHJJoim: The Human Protein Atlas as a proteomic resource for biomarker discovery. 2011, 270(5):428-446.</li>
                <li>Aardema MJ, MacGregor JT: Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies. Mutation research 2002, 499(1):13-25.</li>
                <li>Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, Motyer A, Vukcevic D, Delaneau O, O'Connell J et al: The UK Biobank resource with deep phenotyping and genomic data. Nature 2018, 562(7726):203-209.</li>
                <li>Tomczak K, Czerwińska P, Wiznerowicz M: The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemporary oncology (Poznan, Poland) 2015, 19(1a):A68-77.</li>
                <li>Babu M, Snyder M: Multi-Omics Profiling for Health. Molecular & cellular proteomics : MCP 2023, 22(6):100561.</li>
                <li>Balloux F, Brynildsrud OB, Van Dorp L, Shaw LP, Chen H, Harris KA, Wang H, Eldholm VJTim: From theory to practice: translating whole-genome sequencing (WGS) into the clinic. 2018, 26(12):1035-1048.</li>
                <li>Meienberg J, Bruggmann R, Oexle K, Matyas GJHg: Clinical sequencing: is WGS the better WES? 2016, 135:359-362.</li>
                <li>Alfares A, Aloraini T, Alissa A, Al Qudsi A, Alahmad A, Al Mutairi F, Alswaid A, Alothaim A, Eyaid W, Albalwi MJGiM: Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing. 2018, 20(11):1328-1333.</li>
                <li>Saarenpää S, Shalev O, Ashkenazy H, Carlos V, Lundberg DS, Weigel D, Giacomello SJNb: Spatial metatranscriptomics resolves host–bacteria–fungi interactomes. 2024, 42(9):1384-1393.</li>
                <li>Forward AL, LRS L-RS: Full-Length 16S/18S/ITS Sequencing for Advanced Microbial Diversity Analysis.</li>
                <li>Jiang L, Goh DX, Koh JHZ, Chan X, Brennan NA, Barathi VA, Hoang QV: Applications of Genomics and Transcriptomics in Precision Medicine for Myopia Control or Prevention. Biomolecules 2023, 13(3).</li>
                <li>Sengupta S, Bolin JM, Ruotti V, Nguyen BK, Thomson JA, Elwell AL, Stewart R: Single read and paired end mRNA-Seq Illumina libraries from 10 nanograms total RNA. Journal of visualized experiments : JoVE 2011(56):e3340.</li>
                <li>Tam S, Tsao M-S, McPherson JDJBib: Optimization of miRNA-seq data preprocessing. 2015, 16(6):950-963.</li>
                <li>Huang S, Feng C, Chen L, Huang Z, Zhou X, Li B, Wang LL, Chen W, Lv FQ, Li TS: Identification of Potential Key Long Non-Coding RNAs and Target Genes Associated with Pneumonia Using Long Non-Coding RNA Sequencing (lncRNA-Seq): A Preliminary Study. Medical science monitor : international medical journal of experimental and clinical research 2016, 22:3394-3408.</li>
                <li>Xie Y, Li J, Li P, Li N, Zhang Y, Binang H, Zhao Y, Duan W, Chen Y, Wang YJFio: RNA-Seq profiling of serum exosomal circular RNAs reveals Circ-PNN as a potential biomarker for human colorectal cancer. 2020, 10:982.</li>
                <li>Xu H, Wang C, Song H, Xu Y, Ji GJMc: RNA-Seq profiling of circular RNAs in human colorectal Cancer liver metastasis and the potential biomarkers. 2019, 18:1-6.</li>
                <li>Tong Y, Gao H, Qi Q, Liu X, Li J, Gao J, Li P, Wang Y, Du L, Wang CJT: High fat diet, gut microbiome and gastrointestinal cancer. 2021, 11(12):5889.</li>
                <li>Liu Y, Beyer A, Aebersold R: On the Dependency of Cellular Protein Levels on mRNA Abundance. Cell 2016, 165(3):535-550.</li>
                <li>Yin H, Xie J, Xing S, Lu X, Yu Y, Ren Y, Tao J, He G, Zhang L, Yuan XJCRM: Machine learning-based analysis identifies and validates serum exosomal proteomic signatures for the diagnosis of colorectal cancer. 2024, 5(8).</li>
                <li>Hu A, Noble WS, Wolf-Yadlin A: Technical advances in proteomics: new developments in data-independent acquisition. F1000Research 2016, 5.</li>
                <li>Zhu W, Smith JW, Huang C-MJBri: Mass spectrometry‐based label‐free quantitative proteomics. 2010, 2010(1):840518.</li>
                <li>Megger DA, Bracht T, Meyer HE, Sitek BJBeBA-P, Proteomics: Label-free quantification in clinical proteomics. 2013, 1834(8):1581-1590.</li>
                <li>Cui Y, He L, Yang C-Y, Ye QJCP: iTRAQ and PRM-based quantitative proteomics in early recurrent spontaneous abortion: biomarkers discovery. 2019, 16:1-15.</li>
                <li>Si W, Zhang Y, Li X, Du Y, Xu QJN: Understanding the functional activity of polyphenols using omics-based approaches. 2021, 13(11):3953.</li>
                <li>Temporini C, Calleri E, Massolini G, Caccialanza GJMsr: Integrated analytical strategies for the study of phosphorylation and glycosylation in proteins. 2008, 27(3):207-236.</li>
                <li>Mann M, Jensen ONJNb: Proteomic analysis of post-translational modifications. 2003, 21(3):255-261.</li>
                <li>Peter‐Katalinić JJMie: Methods in enzymology: O‐glycosylation of proteins. 2005, 405:139-171.</li>
                <li>Komander DJBst: The emerging complexity of protein ubiquitination. 2009, 37(5):937-953.</li>
                <li>Bremang M, Cuomo A, Agresta AM, Stugiewicz M, Spadotto V, Bonaldi TJMb: Mass spectrometry-based identification and characterisation of lysine and arginine methylation in the human proteome. 2013, 9(9):2231-2247.</li>
                <li>Satchell DJQR, Chemical Society: An outline of acylation. 1963, 17(2):160-203.</li>
                <li>Idle JR, Gonzalez FJJCm: Metabolomics. 2007, 6(5):348-351.</li>
                <li>Zhang A, Sun H, Wang P, Han Y, Wang XJA: Modern analytical techniques in metabolomics analysis. 2012, 137(2):293-300.</li>
                <li>Wang KC, Chang HYJCr: Epigenomics: technologies and applications. 2018, 122(9):1191-1199.</li>
                <li>Beck D, Ben Maamar M, Skinner MKJE: Genome-wide CpG density and DNA methylation analysis method (MeDIP, RRBS, and WGBS) comparisons. 2022, 17(5):518-530.</li>
                <li>Olova N, Krueger F, Andrews S, Oxley D, Berrens RV, Branco MR, Reik WJGb: Comparison of whole-genome bisulfite sequencing library preparation strategies identifies sources of biases affecting DNA methylation data. 2018, 19:1-19.</li>
                <li>Meissner A, Gnirke A, Bell GW, Ramsahoye B, Lander ES, Jaenisch RJNar: Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. 2005, 33(18):5868-5877.</li>
                <li>Bashtrykov P, Jeltsch AJEEM, Protocols: DNA methylation analysis by bisulfite conversion coupled to double multiplexed amplicon-based next-generation sequencing (NGS). 2018:367-382.</li>
                <li>Buenrostro JD, Wu B, Chang HY, Greenleaf WJJCpimb: ATAC‐seq: a method for assaying chromatin accessibility genome‐wide. 2015, 109(1):21.29. 21-21.29. 29.</li>
                <li>Meng J, Lu Z, Liu H, Zhang L, Zhang S, Chen Y, Rao MK, Huang YJM: A protocol for RNA methylation differential analysis with MeRIP-Seq data and exomePeak R/Bioconductor package. 2014, 69(3):274-281.</li>
                <li>Park PJJNrg: ChIP–seq: advantages and challenges of a maturing technology. 2009, 10(10):669-680.</li>
                <li>Mardis ERJNm: ChIP-seq: welcome to the new frontier. 2007, 4(8):613-614.</li>
                <li>Spruessel A, Steimann G, Jung M, Lee SA, Carr T, Fentz AK, Spangenberg J, Zornig C, Juhl HH, David KA: Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision. BioTechniques 2004, 36(6):1030-1037.</li>
                <li>Kanai Y, Nishihara H, Miyagi Y, Tsuruyama T, Taguchi K, Katoh H, Takeuchi T, Gotoh M, Kuramoto J, Arai E et al: The Japanese Society of Pathology Guidelines on the handling of pathological tissue samples for genomic research: Standard operating procedures based on empirical analyses. Pathology international 2018, 68(2):63-90.</li>
                <li>Li C, Sun YD, Yu GY, Cui JR, Lou Z, Zhang H, Huang Y, Bai CG, Deng LL, Liu P et al: Integrated Omics of Metastatic Colorectal Cancer. Cancer cell 2020, 38(5):734-747.e739.</li>
                <li>Wang C, Wang Y, Chen J, Wang Y, Pang C, Liang C, Yuan L, Ma Y: CLDN18.2 expression and its impact on prognosis and the immune microenvironment in gastric cancer. BMC gastroenterology 2023, 23(1):283.</li>
                <li>Liang B, Wang S, Zhu XG, Yu YX, Cui ZR, Yu YZ: Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer. World journal of gastroenterology 2005, 11(5):623-628.</li>
                <li>Zhao BC, Wang ZJ, Mao WZ, Ma HC, Han JG, Zhao B, Xu HM: CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. World journal of gastroenterology 2011, 17(19):2389-2396.</li>
                <li>Stevens VL, Hoover E, Wang Y, Zanetti KAJM: Pre-analytical factors that affect metabolite stability in human urine, plasma, and serum: a review. 2019, 9(8):156.</li>
                <li>Yang S, McGookey M, Wang Y, Cataland SR, Wu HMJAjocp: Effect of blood sampling, processing, and storage on the measurement of complement activation biomarkers. 2015, 143(4):558-565.</li>
                <li>Krishnan S, Queiroz AT, Gupta A, Gupte N, Bisson GP, Kumwenda J, Naidoo K, Mohapi L, Mave V, Mngqibisa RJFii: Integrative multi-omics reveals serum markers of tuberculosis in advanced HIV. 2021, 12:676980.</li>
                <li>Breier M, Wahl S, Prehn C, Fugmann M, Ferrari U, Weise M, Banning F, Seissler J, Grallert H, Adamski JJPo: Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples. 2014, 9(2):e89728.</li>
                <li>Geyer PE, Voytik E, Treit PV, Doll S, Kleinhempel A, Niu L, Müller JB, Buchholtz ML, Bader JM, Teupser D et al: Plasma Proteome Profiling to detect and avoid sample-related biases in biomarker studies. EMBO molecular medicine 2019, 11(11):e10427.</li>
                <li>López-Bascón MA, Priego-Capote F, Peralbo-Molina A, Calderón-Santiago M, Luque de Castro MD: Influence of the collection tube on metabolomic changes in serum and plasma. Talanta 2016, 150:681-689.</li>
                <li>Cruickshank-Quinn C, Zheng LK, Quinn K, Bowler R, Reisdorph R, Reisdorph N: Impact of Blood Collection Tubes and Sample Handling Time on Serum and Plasma Metabolome and Lipidome. Metabolites 2018, 8(4).</li>
                <li>Sotelo-Orozco J, Chen SY, Hertz-Picciotto I, Slupsky CM: A Comparison of Serum and Plasma Blood Collection Tubes for the Integration of Epidemiological and Metabolomics Data. Frontiers in molecular biosciences 2021, 8:682134.</li>
                <li>Ilies M, Iuga CA, Loghin F, Dhople VM, Thiele T, Völker U, Hammer E: Impact of blood sample collection methods on blood protein profiling studies. Clinica chimica acta; international journal of clinical chemistry 2017, 471:128-134.</li>
                <li>Banks RE, Stanley AJ, Cairns DA, Barrett JH, Clarke P, Thompson D, Selby PJ: Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clinical chemistry 2005, 51(9):1637-1649.</li>
                <li>Leidinger P, Backes C, Rheinheimer S, Keller A, Meese E: Towards Clinical Applications of Blood-Borne miRNA Signatures: The Influence of the Anticoagulant EDTA on miRNA Abundance. PloS one 2015, 10(11):e0143321.</li>
                <li>Xu L, Qu YH, Chu XD, Wang R, Nelson HH, Gao YT, Yuan JM: Urinary levels of N-nitroso compounds in relation to risk of gastric cancer: findings from the shanghai cohort study. PloS one 2015, 10(2):e0117326.</li>
                <li>Chan AW, Mercier P, Schiller D, Bailey R, Robbins S, Eurich DT, Sawyer MB, Broadhurst D: (1)H-NMR urinary metabolomic profiling for diagnosis of gastric cancer. British journal of cancer 2016, 114(1):59-62.</li>
                <li>Chen Y, Zhang J, Guo L, Liu L, Wen J, Xu L, Yan M, Li Z, Zhang X, Nan P et al: A characteristic biosignature for discrimination of gastric cancer from healthy population by high throughput GC-MS analysis. Oncotarget 2016, 7(52):87496-87510.</li>
                <li>Herrington W, Illingworth N, Staplin N, Kumar A, Storey B, Hrusecka R, Judge P, Mahmood M, Parish S, Landray M et al: Effect of Processing Delay and Storage Conditions on Urine Albumin-to-Creatinine Ratio. Clinical journal of the American Society of Nephrology : CJASN 2016, 11(10):1794-1801.</li>
                <li>Jung CE, Chopyk J, Shin JH, Lukacz ES, Brubaker L, Schwanemann LK, Knight R, Wolfe AJ, Pride DT: Benchmarking urine storage and collection conditions for evaluating the female urinary microbiome. Scientific reports 2019, 9(1):13409.</li>
                <li>Wang X, Gu H, Palma-Duran SA, Fierro A, Jasbi P, Shi X, Bresette W, Tasevska N: Influence of Storage Conditions and Preservatives on Metabolite Fingerprints in Urine. Metabolites 2019, 9(10).</li>
                <li>Emwas AH, Luchinat C, Turano P, Tenori L, Roy R, Salek RM, Ryan D, Merzaban JS, Kaddurah-Daouk R, Zeri AC et al: Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review. Metabolomics : Official journal of the Metabolomic Society 2015, 11(4):872-894.</li>
                <li>Koopaie M, Ghafourian M, Manifar S, Younespour S, Davoudi M, Kolahdooz S, Shirkhoda M: Evaluation of CSTB and DMBT1 expression in saliva of gastric cancer patients and controls. BMC cancer 2022, 22(1):473.</li>
                <li>Belstrøm D, Holmstrup P, Bardow A, Kokaras A, Fiehn NE, Paster BJ: Comparative analysis of bacterial profiles in unstimulated and stimulated saliva samples. Journal of oral microbiology 2016, 8:30112.</li>
                <li>Ebersole JL, Schuster JL, Stevens J, Dawson D, 3rd, Kryscio RJ, Lin Y, Thomas MV, Miller CS: Patterns of salivary analytes provide diagnostic capacity for distinguishing chronic adult periodontitis from health. Journal of clinical immunology 2013, 33(1):271-279.</li>
                <li>Scebba F, Salvadori S, Cateni S, Mantellini P, Carozzi F, Bisanzi S, Sani C, Robotti M, Barravecchia I, Martella F et al: Top-Down Proteomics of Human Saliva, Analyzed with Logistic Regression and Machine Learning Methods, Reveal Molecular Signatures of Ovarian Cancer. International journal of molecular sciences 2023, 24(21).</li>
                <li>Yang P, Lei H, Fu Y, Chen C, Tang L, Xia S, Guo Y, Chen G, Xie M, Yang J et al: Exosomal miR-151-3p in saliva: A potential non-invasive marker for gastric cancer diagnosis and prognosis modulated by Sijunzi decoction (SJZD) in mice. Heliyon 2024, 10(7):e29169.</li>
                <li>Rabe A, Gesell Salazar M, Michalik S, Fuchs S, Welk A, Kocher T, Völker U: Metaproteomics analysis of microbial diversity of human saliva and tongue dorsum in young healthy individuals. Journal of oral microbiology 2019, 11(1):1654786.</li>
                <li>Foratori-Junior GA, Ventura TMO, Grizzo LT, Jesuino BG, Castilho A, Buzalaf MAR, Sales-Peres SHC: Is There a Difference in the Proteomic Profile of Stimulated and Unstimulated Saliva Samples from Pregnant Women with/without Obesity and Periodontitis? Cells 2023, 12(10).</li>
                <li>Song M, Bai H, Zhang P, Zhou X, Ying B: Promising applications of human-derived saliva biomarker testing in clinical diagnostics. International journal of oral science 2023, 15(1):2.</li>
                <li>Yang HJ, Seo SI, Lee J, Huh CW, Kim JS, Park JC, Kim H, Shin H, Shin CM, Park CH et al: Sample Collection Methods in Upper Gastrointestinal Research. Journal of Korean medical science 2023, 38(32):e255.</li>
                <li>Duarte D, Castro B, Pereira JL, Marques JF, Costa AL, Gil AM: Evaluation of Saliva Stability for NMR Metabolomics: Collection and Handling Protocols. Metabolites 2020, 10(12).</li>
                <li>Mills RH, Dulai PS, Vázquez-Baeza Y, Sauceda C, Daniel N, Gerner RR, Batachari LE, Malfavon M, Zhu Q, Weldon K et al: Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity. Nature microbiology 2022, 7(2):262-276.</li>
                <li>Nechvatal JM, Ram JL, Basson MD, Namprachan P, Niec SR, Badsha KZ, Matherly LH, Majumdar AP, Kato I: Fecal collection, ambient preservation, and DNA extraction for PCR amplification of bacterial and human markers from human feces. Journal of microbiological methods 2008, 72(2):124-132.</li>
                <li>Bassis CM, Moore NM, Lolans K, Seekatz AM, Weinstein RA, Young VB, Hayden MK: Comparison of stool versus rectal swab samples and storage conditions on bacterial community profiles. BMC microbiology 2017, 17(1):78.</li>
                <li>Cunningham JL, Bramstång L, Singh A, Jayarathna S, Rasmusson AJ, Moazzami A, Müller B: Impact of time and temperature on gut microbiota and SCFA composition in stool samples. PloS one 2020, 15(8):e0236944.</li>
                <li>Widjaja F, Rietjens I: From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes. Biomedicines 2023, 11(10).</li>
                <li>Wu SZ, Roden DL, Al-Eryani G, Bartonicek N, Harvey K, Cazet AS, Chan CL, Junankar S, Hui MN, Millar EA et al: Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis. Genome medicine 2021, 13(1):81.</li>
                <li>Shabihkhani M, Lucey GM, Wei B, Mareninov S, Lou JJ, Vinters HV, Singer EJ, Cloughesy TF, Yong WH: The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings. Clinical biochemistry 2014, 47(4-5):258-266.</li>
                <li>Sandusky GE, Teheny KH, Esterman M, Hanson J, Williams SD: Quality control of human tissues--experience from the Indiana University Cancer Center-Lilly Research Labs human tissue bank. Cell and tissue banking 2007, 8(4):287-295.</li>
                <li>Ghatak S, Muthukumaran RB, Nachimuthu SK: A simple method of genomic DNA extraction from human samples for PCR-RFLP analysis. Journal of biomolecular techniques : JBT 2013, 24(4):224-231.</li>
                <li>Mullegama SV, Alberti MO, Au C, Li Y, Toy T, Tomasian V, Xian RR: Nucleic Acid Extraction from Human Biological Samples. Methods in molecular biology (Clifton, NJ) 2019, 1897:359-383.</li>
                <li>Michalska-Falkowska A, Niklinski J, Juhl H, Sulewska A, Kisluk J, Charkiewicz R, Ciborowski M, Ramlau R, Gryczka R, Piwkowski C et al: Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach. Cancers 2023, 15(14).</li>
                <li>Sheng Q, Vickers K, Zhao S, Wang J, Samuels DC, Koues O, Shyr Y, Guo Y: Multi-perspective quality control of Illumina RNA sequencing data analysis. Briefings in functional genomics 2017, 16(4):194-204.</li>
                <li>Gaignaux A, Ashton G, Coppola D, De Souza Y, De Wilde A, Eliason J, Grizzle W, Guadagni F, Gunter E, Koppandi I et al: A Biospecimen Proficiency Testing Program for Biobank Accreditation: Four Years of Experience. Biopreservation and biobanking 2016, 14(5):429-439.</li>
                <li>Brown RE, Jarvis KL, Hyland KJJAb: Protein measurement using bicinchoninic acid: elimination of interfering substances. 1989, 180(1):136-139.</li>
                <li>Simard JR, Lee L, Vieux E, Improgo R, Tieu T, Phillips AJ, Fisher SL, Pollock RM, Park EJSDAtSoDD: High-throughput quantitative assay technologies for accelerating the discovery and optimization of targeted protein degradation therapeutics. 2021, 26(4):503-517.</li>
                <li>Shickle DJSiH, History PoSPCSi, Biological Po, Sciences B: The consent problem within DNA biobanks. 2006, 37(3):503-519.</li>
                <li>Munshi R, Thatte UJPicr: Compensation for research related injury. 2013, 4(1):61-69.</li>
                <li>Henry LM, Larkin ME, Pike ERJJoL, Biosciences t: Just compensation: a no-fault proposal for research-related injuries. 2015, 2(3):645-668.</li>
                <li>Smith-Tyler JJPotATS: Informed consent, confidentiality, and subject rights in clinical trials. 2007, 4(2):189-193.</li>
                <li>D'Abramo F, Schildmann J, Vollmann JJBme: Research participants' perceptions and views on consent for biobank research: a review of empirical data and ethical analysis. 2015, 16:1-11.</li>
                <li>Reilly J, Gallagher L, Chen JL, Leader G, Shen SJMA: Bio-collections in autism research. 2017, 8:1-36.</li>
                <li>Kaufman DJ, Murphy-Bollinger J, Scott J, Hudson KLJTAJoHG: Public opinion about the importance of privacy in biobank research. 2009, 85(5):643-654.</li>
                <li>Biobank UJUB: UK Biobank ethics and governance framework. 2007, 3.</li>
                <li>Staunton C, Moodley KJSSAMJ: Data mining and biological sample exportation from South Africa: A new wave of bioexploitation under the guise of clinical care? 2016, 106(2):136-138.</li>
                <li>Zhang X, Matsui K, Krohmal B, Zeid AA, Muthuswamy V, Koo YM, Kita Y, Lie RKJBme: Attitudes towards transfers of human tissue samples across borders: an international survey of researchers and policy makers in five countries. 2010, 11:1-7.</li>
                <li>Frascarelli C, Bonizzi G, Musico CR, Mane E, Cassi C, Guerini Rocco E, Farina A, Scarpa A, Lawlor R, Reggiani Bonetti LJJoPM: Revolutionizing cancer research: the impact of artificial intelligence in digital biobanking. 2023, 13(9):1390.</li>
                <li>Bonizzi G, Zattoni L, Fusco N: Biobanking in the digital pathology era. Oncology research 2021, 29(4):229-233.</li>
                <li>Issaq HJ, Waybright TJ, Veenstra TD: Cancer biomarker discovery: Opportunities and pitfalls in analytical methods. Electrophoresis 2011, 32(9):967-975.</li>
                <li>Lin L-L, Huang H-C, Juan H-FJJop: Discovery of biomarkers for gastric cancer: a proteomics approach. 2012, 75(11):3081-3097.</li>
                <li>Shi X-J, Wei Y, Ji BJFiMB: Systems biology of gastric cancer: Perspectives on the omics-based diagnosis and treatment. 2020, 7:203.</li>
                <li>Ma Y, Jiang Z, Pan L, Zhou Y, Xia R, Liu Z, Yuan LJIJoO: Current development of molecular classifications of gastric cancer based on omics. 2024, 65(3):1-22.</li>
                <li>Fu Q, Murray CI, Karpov OA, Van Eyk JEJMSR: Automated proteomic sample preparation: The key component for high throughput and quantitative mass spectrometry analysis. 2023, 42(2):873-886.</li>
                <li>More D, Khan N, Tekade RK, Sengupta PJCRiAC: An update on current trend in sample preparation automation in bioanalysis: Strategies, challenges and future direction. 2024:1-25.</li>
                <li>Mamo N, Martin GM, Desira M, Ellul B, Ebejer J-PJEJoHG: Dwarna: a blockchain solution for dynamic consent in biobanking. 2020, 28(5):609-626.</li>
            </ol>
        </section>
    </main>

    <footer>
        <p>&copy; 2024 A framework for Multi-Omics based Biobank | <i class="fas fa-envelope"></i> Contact Us: fuyang@zzu.edu.cn</p>
    </footer>
    
    <script>
        document.addEventListener('DOMContentLoaded', function() {
            // Animate elements when they come into view
            const sections = document.querySelectorAll('section');
            const observer = new IntersectionObserver((entries) => {
                entries.forEach(entry => {
                    if (entry.isIntersecting) {
                        entry.target.classList.add('visible');
                    }
                });
            }, { threshold: 0.2 });
            
            sections.forEach(section => {
                observer.observe(section);
            });
        });
    </script>
</body>
</html> 
